White Guide and Orange Guide Formatting Project - Pfizer

Use of RC-Approved Slides/Content
Orange Guide – Chapter 9: Speaker Programs for HCPs
Q. Can a speaker at a Pfizer promotional program for HCPs describe a case study
during his or her presentation?
A. During a speaker program, a speaker may verbally describe a case study if their
comments are consistent with the approved slides and product labeling and if
they make clear that their comments are based on their personal experience.
Q. Can a speaker add case study slides? Can he or she add slides that are approved
for use by Pfizer Medical, Public Policy, or other non-commercial colleagues?
A. No. Speakers may only present and speak to slides from RC-approved slide
decks. A speaker may not add slides to the presentation that have been
approved by Pfizer for other (e.g., Medical or Policy Group) uses. In very limited
instances, a speaker can obtain pre-approval from the Review Committee to
present slides that are not contained in the EZSpeak slide kit through the
Exceptions Process.
Use of Unapproved On-Label Clinical Reprints
Q. Can a speaker present data from an unapproved clinical reprint that is
substantiated, scientifically sound and seems to be on-label but is not RCapproved?
A. No. All information presented must be RC-approved. A speaker at a
promotional program represents Pfizer and must follow the same promotional
policies as a member of the Pfizer sales force, with two exceptions:
Roundtables and Use of Approved Materials
1. He or she may provide off-label information or refer to an unapproved
clinical study (if appropriate) only in response to a specific, unsolicited
question; and
2. He or she may create and use his or her own slides only if they are
approved by the Review Committee prior to the speaker program in
accordance with the Exceptions Process.
Q. When a speaker is presenting information to a small group of HCPs in a
“roundtable” format, does the speaker have to use Pfizer approved slides?
A. Yes, a speaker must always use only RC-approved slides. Where projecting the
approved slides is not feasible, the approved Pfizer slides may be handed out
(in their entirety) to attendees, unless prohibited by the product review
committee. The relevant product package insert must also be made available
to all attendees.
160
Rev. 09/12
Page 9 of 25